女性压力性尿失禁手术治疗更新:AUA/SUFU指南(2023)
该指南由AUA/SUFU制定,旨在为女性压力性尿失禁(SUI)的诊断、咨询和治疗提供临床框架。本次修订基于截至2022年2月的更新文献,保留索引患者与非索引患者的区分,索引患者为无或轻度脱垂、希望手术治疗的纯SUI或压力主导型混合性尿失禁的健康女性。
要点
- 索引患者:健康女性,无或轻度脱垂,纯SUI或压力主导型混合性尿失禁,希望手术治疗。
- 非索引患者因素包括:高级别脱垂(3或4级)、急迫主导型混合性尿失禁、神经源性下尿路功能障碍等。
- 指南基于截至2022年2月的文献更新,未来将继续修订以保持最高护理水平。
核心结论
- 尽管SUI诊断、治疗和随访的新方法不断涌现,该领域仍在扩展,未来将进行指南修订以保持最高患者护理水平。
研究设计与样本
- 制定机构为AUA/SUFU,方法为系统文献综述(主要来源为ECRI Institute),初始检索2005年1月至2015年12月,补充摘要检索至2016年9月,本次更新检索截至2022年2月。
主要发现
- 指南已修订以反映2017年以来的文献变化和新增内容。
- 专家组维持索引患者与非索引患者的区分重要性。
- 索引患者为健康女性,无或轻度脱垂,希望手术治疗纯SUI或压力主导型混合性尿失禁。
- 非索引患者具有可能影响治疗选择和结局的因素,如高级别脱垂(3或4级)、急迫主导型混合性尿失禁、神经源性下尿路功能障碍、膀胱排空不全、排尿功能障碍、抗尿失禁治疗后SUI、mesh并发症、高体重指数或高龄。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this guideline is to provide a clinical structure with which to approach the diagnosis, counseling, and treatment of female patients with stress urinary incontinence (SUI). MATERIALS/METHODS: The primary source of evidence for the 2017 version of the SUI guideline was the systematic literature review conducted by the ECRI Institute. The initial search spanned literature from January 2005 to December 2015, with an additional updated abstract search through September 2016. The current amendment represents the first update to the 2017 iteration and includes updated literature published through February 2022. RESULTS: This guideline has been amended to reflect changes in and additions to the literature since 2017. The Panel maintained that the differentiation between index and non-index patients remained important. The index patient is a healthy female with minimal or no prolapse who desires surgical therapy for treatment of pure SUI or stress-predominant mixed urinary incontinence. Non-index patients have factors that may affect their treatment options and outcomes, such as high grade prolapse (grade 3 or 4), urgency-predominant mixed incontinence, neurogenic lower urinary tract dysfunction, incomplete bladder emptying, dysfunctional voiding, SUI following anti-incontinence treatment, mesh complications, high body mass index, or advanced age. CONCLUSION: While gains have been made in the field to support new methods for the diagnosis, treatment, and follow-up of patients with SUI, the field continues to expand. As such, future reviews of this guideline will take place to stay in keeping with the highest levels of patient care.
引用
- Kobashi KC, Vasavada S, Bloschichak A, et al. Updates to Surgical Treatment of Female Stress Urinary Incontinence (SUI): AUA/SUFU Guideline (2023). J Urol. 2023. PMID: 37096580. doi:10.1097/JU.0000000000003435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。